Literature DB >> 22858272

Clinical outcomes of redo valvular operations: a 20-year experience.

Naoto Fukunaga1, Yukikatsu Okada, Yasunobu Konishi, Takashi Murashita, Mitsuru Yuzaki, Yu Shomura, Hiroshi Fujiwara, Tadaaki Koyama.   

Abstract

BACKGROUND: A higher operative mortality rate has been reported after redo valvular procedures than after the primary operation.
METHODS: Outcomes of 330 consecutive patients undergoing 433 redo valvular operations at our institute during a 20-year period (January 1990 to December 2010) were reviewed retrospectively. The mean follow-up was 6.4 years (range, 0.05 to 1.3 years). Logistic regression analysis was used to identify factors associated with hospital death.
RESULTS: The overall hospital mortality rate was 6.7% (29 of 433 procedures). Logistic regression analysis identified only advanced New York Heart Association (NYHA) class as an independent predictor of hospital death. Overall survival at 5, 10, and 15 years was 83.6%±2.2%, 70.7%±3.4%, and 61.5%±4.5%, respectively. The 5-, 10-, and 15-year survivals for the first redo vs more than second redo groups were 86.5%±2.4% vs 74.7%±5.5%, 71.8%±3.9% vs 66.8%±6.6%, and 60.2%±5.7% vs 63.1%±7.2%, respectively (log-rank P=0.505). The 5- and 10-year survivals for NYHA class I/II vs III/IV patients were 91.5%±2.1% vs 70.4%±4.5% and 77.8%±4.1% vs 58.5%±5.6%, respectively (log-rank p<0.005).
CONCLUSIONS: Redo valvular operation in NYHA class III/IV patients is associated with high hospital death and poor long-term survival. To achieve low hospital death and good long-term survival, redo operations, including more than third redo operations, should be performed in patients with lower NYHA class.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858272     DOI: 10.1016/j.athoracsur.2012.06.045

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Clinical outcome of redo operation on aortic root.

Authors:  Naoto Fukunaga; Tadaaki Koyama; Yasunobu Konishi; Takashi Murashita; Hideo Kanemitsu; Yukikatsu Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-10-18

2.  Parsimonious assessment for reoperative aortic valve replacement; the deterrent effect of low left ventricular ejection fraction and renal impairment.

Authors:  Maroun Yammine; Fernando Ramirez-Del Val; Julius I Ejiofor; Robert C Neely; Diana Shi; Siobhan McGurk; Sary F Aranki; Tsuyoshi Kaneko; Prem S Shekar
Journal:  Ann Cardiothorac Surg       Date:  2017-09

Review 3.  Pathophysiology and management of multivalvular disease.

Authors:  Philippe Unger; Marie-Annick Clavel; Brian R Lindman; Patrick Mathieu; Philippe Pibarot
Journal:  Nat Rev Cardiol       Date:  2016-04-28       Impact factor: 32.419

Review 4.  Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation.

Authors:  Pier Pasquale Leone; Fabio Fazzari; Francesco Cannata; Jorge Sanz-Sanchez; Antonio Mangieri; Lorenzo Monti; Ottavia Cozzi; Giulio Giuseppe Stefanini; Renato Bragato; Antonio Colombo; Bernhard Reimers; Damiano Regazzoli
Journal:  Front Cardiovasc Med       Date:  2021-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.